TNFSF13 and neoplasm: In conclusion, the use of two distinct antibodies that differentiate APRIL producer cells from target cells, combined with appropriate cell markers, allowed us to demonstrate that tumor B cells in GML are targeted by this cytokine, which is produced by tumor-infiltrating eosinophilic polynuclear cells.